Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

FDA advisory panel denies approval for Genzyme's Sepracoat

May 8, 1997

Abbott discovers potent topical immunosuppressant with minimal systemic effects

April 30, 1997

Positive phase III results from Hyal's actinic keratosis trial

April 28, 1997

Gliatech's ADCON-L to recieve expedited review by FDA

April 24, 1997

LifeCell reports clinical data on AlloDerm

April 23, 1997

Promising data reported from pilot trial of Lubricoat Gel for adhesions

April 17, 1997

Another minoxidil generic approved in U.S. for women

April 16, 1997

Generic minoxidil receives FDA approval

April 16, 1997

Faulding launches wound care line in Australia and New Zealand

April 15, 1997

Merck & Co. prepares cytokine inhibitors

April 15, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026